CTEP
≈ 1 min read
Names in other languages
- EnglishCTEP
- shCTEP
- СрпскиCTEP
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR 5 , binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR 5 antagonists such as MPEP, MTEP and fenobam.
CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR 5 , binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR 5 antagonists such as MPEP, MTEP and fenobam.
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1376983489 under CC BY-SA 4.0; modifications have been made.